日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of talquetamab in relapsed/refractory multiple myeloma and renal impairment: a quaternary cancer center cohort

talquetamab治疗复发/难治性多发性骨髓瘤合并肾功能损害的疗效和安全性:一项四级癌症中心队列研究

Ali, Hossam M; Mazzoni, Sandra; Goel, Utkarsh; Khouri, Jack; Anwer, Faiz; Williams, Louis S; Basali, Diana; Samaras, Christy J; Faiman, Beth M; Van Heeckeren, Willem; Hamilton, Kimberly; Rudoni, Joslyn; Rice, Mikhaila; Kissam, Jonathan; Scott, Cynthia; Mathur, Saveta; McDonald, Alexandra; Roy, Tara; Bevacqua, Julie; Pasquini, Marcelo C; Valent, Jason; Raza, Shahzad

Current management of non-amyloidosis monoclonal gammopathy of renal significance: Clinical features, treatment selections, responses and renal outcomes

目前非淀粉样变性单克隆丙种球蛋白病(肾脏相关)的治疗管理:临床特征、治疗选择、疗效及肾脏预后

Cancilla, Daniel; Sawaf, Hanny; Jia, Xuefei; Dima, Danai; Mehdi, Ali; Shaikh, Hira; Faiman, Beth; Anwer, Faiz; Mazzoni, Sandra; Basali, Diana; Khouri, Jack; Samaras, Christy; Valent, Jason; Raza, Shahzad; Williams, Louis

Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: 14-Year Experience of an Academic Center

局部免疫球蛋白轻链淀粉样变性的表现和预后:一家学术中心14年的经验

Dima, Danai; Goel, Utkarsh; Ullah, Fauzia; Faiman, Beth; Basali, Diana; Mazzoni, Sandra; Williams, Louis S; Samaras, Christy; Valent, Jason; Anwer, Faiz; Khouri, Jack; Raza, Shahzad

Real-world data on safety and efficacy of venetoclax-based regimens in relapsed/refractory t(11;14) multiple myeloma

维奈托克方案治疗复发/难治性t(11;14)多发性骨髓瘤的真实世界安全性和有效性数据

Basali, Diana; Chakraborty, Rajshekhar; Rybicki, Lisa; Rosko, Nathaniel; Reed, Janice; Karam, Maryann; Schlueter, Kristen; Dysert, Hayley; Kalaycio, Matt; Valent, Jason

Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells

瘦素受体维持三阴性乳腺癌细胞的癌干细胞样特性

Zheng, Qiao; Banaszak, Lauren; Fracci, Sarah; Basali, Diana; Dunlap, Sarah M; Hursting, Stephen D; Rich, Jeremy N; Hjlemeland, Anita B; Vasanji, Amit; Berger, Nathan A; Lathia, Justin D; Reizes, Ofer